Visionary Venture Fund — an Orange County based ophthalmology focused venture fund — and Orange County's technology and life sciences accelerator organization OCTANE recently announced the close of the fund's first round of funding, which will reportedly allow Visionary Venture Fund invest up to $30 million in about a dozen promising ophthalmology companies over the next 18 months.
According to Visionary Venture Fund, Southern California has a concentration of ophthalmology innovation to strong innovation at its universities, healthcare institutions and advanced manufacturing, pharmaceutical and medical device industries. The company's Key Opinion Leader Ophthalmology partners and Investment Committee reportedly assist in deciding which companies receive funding.
Examples of companies that received investment during this round of funding include:
- IanTech, an organization working on a minimally invasive micro-interventional device to treat cataracts in a safe and cost-effective manner.
- Mynosys, a group developing a device that uses precision pulse technology to create an accurate and reproducible capsulotomy.
- SightLife Surgical, the leading eye bank and specialist in providing corneal tissue and services to cornea surgeons. The company plans to eliminate corneal blindness worldwide.
- RxSight, a pioneering IOL product expected to transform the lens industry by being able to tune vision after cataract surgery.
Click here to read the full press release.
Like what you read? Follow OphthalmologyWeb to keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.
Source: Visionary Venture Fund